Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sudlow, C.L.M.
Right arrow Articles by Warlow, C.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sudlow, C.L.M.
Right arrow Articles by Warlow, C.P.

(Stroke. 1997;28:491-499.)
© 1997 American Heart Association, Inc.


Articles

Comparable Studies of the Incidence of Stroke and its Pathological Types

Results From an International Collaboration

C.L.M. Sudlow, MRCP(UK); C.P. Warlow, FRCP; for the International Stroke Incidence Collaboration

From the Department of Clinical Neurosciences, University of Edinburgh (Scotland).

Correspondence to Dr Cathie Sudlow, Registrar in Medical Neurology, Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Crewe Rd, Edinburgh EH4 2XU, Scotland.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowAppendix 1
down arrowReferences
 
Background and Purpose Comparing stroke rates in different parts of the world may increase our understanding of both etiology and prevention. However, comparisons are meaningful only if studies use standard definitions and methods, with comparably presented data. We compared the incidence of stroke and its pathological types (cerebral infarction, primary intracerebral hemorrhage, and subarachnoid hemorrhage) in recent studies from around the world.

Methods Studies with a midyear of 1984 or later, fulfilling standard criteria for a comparable, community-based study, provided original data for comparative analyses.

Results By mid-1995, data were available from 11 studies in Europe, Russia, Australasia, and the United States, comprising approximately 3.5 million person-years and 5575 incident strokes. Age- and sex-standardized annual incidence rates for subjects aged 45 to 84 years were similar (between approximately 300/100 000) and 500/100 000) in most places but were significantly lower in Dijon, France (238/100 000), and higher in Novosibirsk, Russia (627/100 000). In subjects aged 75 to 84 years, however, Novosibirsk no longer ranked higher than the other studies. The distribution of pathological types, when these were reliably distinguished, did not differ significantly between studies.

Conclusions The similarities in stroke incidence and pathological types are perhaps not surprising given that all the populations were westernized and mainly white. The higher rates in Novosibirsk, disappearing in the elderly, and the lower rates in Dijon have several potential explanations. These include methodological artifact and different patterns of population risk factors. Further work is needed to explore these possibilities and to extend our knowledge of stroke incidence to other parts of the world, especially developing countries.


Key Words: epidemiology • incidence • stroke, acute


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowAppendix 1
down arrowReferences
 
Comparing rates of disease in different parts of the world and attempting to determine factors to explain any differences have often led to important knowledge about etiology and prevention. For stroke, however, there are problems in comparing rates on an international scale. Mortality statistics, when available, are a convenient starting point but are limited by inaccuracy, variable diagnostic and coding methods, and the absence of information on nonfatal strokes.1 2 In addition, stroke is not a single disease but a clinical syndrome with several different pathologies; these are not distinguished reliably in death certificates and some—lacunar strokes, for example—are rarely fatal. Stroke incidence (and case fatality) should be much more informative, but accurate data can be obtained only by rigorously conducted studies adhering to criteria that make their results comparable with each other. We believe that these criteria should be based on those of Malmgren et al,3 and they are discussed in detail elsewhere.2 The review of Malmgren et al, published in 1987, found only nine of a potential 65 studies whose incidence rates for all types of stroke combined could be reasonably compared.4 5 6 7 8 9 10 11 12 13 14 Such studies are therefore rare, and what we know of stroke incidence on a worldwide scale remains very limited, being largely confined to developed, westernized countries.

However, our knowledge of the worldwide situation is slowly growing as further comparable studies emerge. The ongoing WHO MONICA project has recently published stroke incidence figures from participating centers in Europe, Russia, and China.15 This is a landmark study in stroke epidemiology, but it has some limitations: many parts of the world are not represented; no center includes subjects aged >75 years (in whom the burden of stroke is greatest), and many stop at 65 years (thereby excluding approximately 75% of all strokes); the study is not designed to investigate accurately different pathological types of stroke; and many centers use the semiretrospective "cold pursuit" method of case finding, which is more suitable for monitoring time trends within individual studies (the main aim of the MONICA project) than for comparing rates between studies.

However, data from other potentially comparable incidence studies that were not initially established as part of an international effort can be used to contribute to the broadening knowledge of worldwide patterns of stroke incidence. Moreover, with the wider availability of CT scanning, an increasing number of studies can provide reliable information on the incidence of the different pathological types of stroke: CI, PICH, and SAH. This article presents the results of comparisons from a collaborative group of recent studies. Most of these monitored stroke in subjects aged up to and over 85 years. For studies with high rates of accurate diagnosis of pathological types of stroke, a comparison of the incidence rates of pathological types is included.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowAppendix 1
down arrowReferences
 
Developing Standard Criteria
Based on the work of Malmgren et al,3 supplemented by the experiences of stroke incidence studies undertaken more recently, we established an updated set of criteria for comparable studies of stroke incidence. These are summarized in Table 1Down and discussed fully in an earlier report.2


View this table:
[in this window]
[in a new window]
 
Table 1. Criteria for Comparable Studies of Stroke Incidence Used in This Analysis (Adapted From Sudlow and Warlow2 )

Study Selection
Stage 1: Search Strategy
We searched for studies performed recently (midyear of study 1984 or later) that might contribute to an up-to-date "snapshot" of stroke incidence around the world. We used the American Library of Medicine Medline and Popline databases and the Bath Information Data Services' Embase to identify studies. Reference lists of stroke incidence studies and relevant review articles were also examined. Several journals with an interest in stroke epidemiology were inspected prospectively during the last 12 years by one of the authors (C.P.W.). Finally, we asked collaborators and international colleagues to inform us of any potentially comparable studies.

Studies that are part of the WHO MONICA project,15 even if independently published, were not included in this comparison because they form a well-defined group that is being analyzed separately. Therefore, this is not a complete systematic review but rather an attempt to bring together currently available knowledge from independent groups of investigators.

Stage 2: Examining Written Reports of Studies
We examined the publications and available unpublished manuscripts from all identified studies. Studies were excluded when it was clear that the standard definitions and methods outlined in Table 1Up had not been used, with one exception: the Mayo Clinic in Rochester, Minn, has a unique records system, reliably documenting all medical presentations from the level of primary care upward.16 In this case only, we considered retrospective methods of case identification to be as reliable (or nearly as reliable) as prospective ones. Emphasis was placed on the importance of complete, community-based case ascertainment. Studies that did not clearly attempt to identify cases managed outside the hospital were excluded.

Stage 3: Seeking Information Not Included in Written Reports
For all potentially comparable studies, we not only used the written reports but also sought unpublished details from the authors to confirm the use of standard definitions and methods. This included one of the authors (C.L.M.S.) visiting almost all the centers of potentially "ideal" studies in late 1994. For each study, we established the range of case-finding procedures and their relevance to the local healthcare system, ensuring (as far as possible) that all potential sources of cases had been identified. Our minimum criteria for adequate case ascertainment methods are shown in Table 2Down.


View this table:
[in this window]
[in a new window]
 
Table 2. Minimum Criteria for Adequate Case Ascertainment

Stage 4: Data Collection
The studies selected provided original data in a standard format, with actual numbers of first-ever-in-a-lifetime strokes and population figures in 5-year age bands for men and women separately. Ten-year age bands were used in two studies17 18 19 in which 5-year breakdowns for the denominator were unavailable. Most studies had collected data on strokes for all age groups and could provide information for subjects aged up to and over 85 years. We avoided averaging data collected over periods of >5 years. For studies running continuously or intermittently for >5 years, the most recent set of data was used.

Stage 5: Selecting Studies for Comparisons of Pathological Types of Stroke
Studies with a high rate of diagnosis of pathological types, which used diagnostic definitions as outlined in Table 3Down and discussed previously,2 provided data in the same format as described above for each of the pathological types. We considered a "definite" pathological diagnosis rate of >70% of incident strokes (ie, <30% "undetermined" or "probable") to be high enough to make the results reasonably representative of the true distribution of pathological types. This effectively meant a minimum CT scan rate of approximately 70%, because the number of cases assigned a definite pathology purely on the basis of autopsy or other investigations was small in all studies. When this condition was met, we considered it acceptable for some of the cases without a definite pathological type to be assigned a probable pathological type (CI or PICH) based on a validated clinical score.2 For all studies, we assumed that the vast majority of SAHs could be diagnosed reliably with the use of mainly clinical and cerebrospinal fluid criteria, making all strokes of undetermined pathology either PICH or CI. This meant that as long as they used the criteria in Table 3Down, studies with lower rates of CT scanning could provide separate information on SAHs but not on other pathological types.


View this table:
[in this window]
[in a new window]
 
Table 3. Standard Definitions for Comparing Pathological Types of Stroke

The comparison included all studies selected as described above with data made available to us by mid-1995.

Data Analysis
Incidence rates were calculated from the data provided for each study, and comparisons between studies were made with the use of direct age standardization to Segi's European population.20 In this comparison, the study populations resemble this notional population structure more closely than Segi's world population,20 which would be more appropriate for the truly worldwide comparison that is not yet possible. The distribution of ages in the population within the open-ended upper age band may vary between studies, and therefore if this age band is included in estimates of age-standardized rates, the results may not be comparable between studies. Age-standardized rates for comparisons were therefore based on closed bands: 45 to 84 or 45 to 74 years. Data combining both men and women were standardized to a notional population with a male-to-female ratio of 1:1 (direct sex standardization). For analysis of rates of pathological types, in studies in which a clinical score was used as described above, the definite and probable categories for CI and PICH were combined.

We calculated confidence intervals by assuming a Poisson distribution of incident strokes over time.21 For the Auckland study, a more complex adaptation of the standard method had to be used because one quarter of the study population was used for monitoring out-of-hospital cases.22


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowAppendix 1
down arrowReferences
 
Studies and Characteristics
From a total of 35 studies of stroke incidence (excluding WHO MONICA studies) of mid-year 1984 or later, published by the end of 1994 or unpublished but known to us at that stage, 11 were selected according to the methods described. Several important features of these are summarized in Table 4Down. One of the studies (Söderhamn, Sweden) is unpublished, but the methods are the same as those used in previous studies by the same investigator in the same location.4 13 An appendix listing all the studies reviewed and reasons for exclusion can be obtained from the authors on request. We continue to seek details from several very recent studies as part of the ongoing collaborative effort.


View this table:
[in this window]
[in a new window]
 
Table 4. Characteristics of Comparable Stroke Incidence Studies Included in This Analysis

The Oxfordshire study population was not geographically discrete, with the denominator based on the age/sex registers of general practice populations.23 All the other studies defined their population according to geographic boundaries of all or part of a town or city, with denominator numbers derived from official census data. Because the studies collected cases for a variable period of time, the person-years studied are a variable multiple of the population size. The total number of strokes is also an important determinant of the statistical precision of incidence estimates. Table 4Up also shows the variability in hospital admission rates for stroke. In most studies, a substantial minority were not admitted, demonstrating the importance of a comprehensive out-of-hospital case-finding system. All the studies fulfilled our minimum criteria for case ascertainment. However, there were considerable differences in the way that these were achieved, particularly the maintenance of contact with primary health care, involving frequent general practice visits by study nurses or neurologists in some studies and relying on regular written reminders to general practitioners to refer all suspected stroke and TIA cases in others. Most studies made use of hospital discharge lists as well as admissions, and most used a variety of other case-finding methods, depending on the local healthcare system. For example, emergency ambulance calls were monitored daily in Novosibirsk,34 and in several studies routine investigations of requests to CT scanning and carotid ultrasound departments were made. All except the Rochester study (see above) used prospective methods, with a study specialist assessing the majority of potential stroke cases, usually within a few days of the event. In the Rochester study all records for potential stroke cases were reviewed by a study neurologist.

Incidence Rates
Our calculated incidence rates sometimes yielded different results from those in existing publications. For example, ongoing case finding in the Auckland study33 discovered some extra cases not known about when the results of the study were first published, although these were too few (four) to make any meaningful difference to the results. The original publications of the Perth study included 18 months of strokes,30 but in this analysis only the first-year data were used to avoid the possible effect of seasonal fluctuations in incidence rates. Published work from the Dijon study included as CIs all cases of TIA with a visible infarct on CT scan.24 25 Because we sought to compare rates of stroke as defined by the WHO, with symptoms lasting beyond 24 hours, TIAs were excluded in the Dijon data set used for this comparison. In a recent publication by the Rochester group, incidence rates are estimated with a denominator corrected for prevalent cases (ie, those no longer at risk of a first-ever stroke are removed from the denominator).27 No other study has been able to adjust for prevalence in this way, and therefore for this comparison we have not adjusted the Rochester population denominator.

Rates for All Types of Stroke Combined
The Warsaw study is not included here because SAHs were not registered, and therefore total stroke rates are not known.32 Fig 1Down shows the incidence of all types of stroke combined, in 10-year age bands from 45 to 54 up to >=85 years . Data are sex-standardized within each age band. As expected, a rise in stroke incidence with age is seen for all studies, with the vast majority of strokes occurring in those aged >=65 years. The rate of this rise varies between studies with especially wide variation in those aged >85 years. Smaller population numbers in this age band limit the precision of rate estimates, which have wide confidence intervals. It is also an open-ended upper age band with potential variability arising from different age distributions within this band in each study.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 1. Annual incidence per 100 000 of all types of stroke combined with increasing age, sex-standardized within 10-year age bands. Error bars show upper 95% confidence intervals. The studies are in the same order for each age band, such that they appear in rank order for the group aged 75 to 84 years, the closed age band with the highest incidence rates.

Fig 2Down shows age- and sex-standardized incidence rates for all types of stroke combined for subjects aged 45 to 84 years and age-standardized incidence rates for men and women separately for the same age group. When we allow for the statistical imprecision of the estimates, the results suggest a similar annual stroke incidence for most studies, with the age- and sex-standardized rate lying somewhere between approximately 300/100 000 and 500/100 000. However, Dijon, at 238/100 000, had a significantly lower rate, and Novosibirsk, at 627/100 000, had a rate more than 2.5-fold that in Dijon. Men had consistently higher incidence rates than women. The tendency for rates to be lower in Dijon and higher in Novosibirsk was maintained when the sexes were considered separately.



View larger version (36K):
[in this window]
[in a new window]
 
Figure 2. Age- and sex-standardized annual incidence per 100 000 of all types of stroke combined for the group aged 45 to 84 years and age-standardized annual incidence per 100 000 of all types of stroke combined for the group aged 45 to 84 years, with men and women considered separately. Studies are arranged in ascending order of age- and sex-standardized incidence rates. The numbers shown are point estimates, and the error bars are 95% confidence intervals.

If the oldest age group for which a closed age band is available (ie, 75 to 84 years) is considered, the variation in incidence rates between countries, shown in Fig 3Down, is somewhat different. In particular, Novosibirsk, which from Fig 2Up had by far the highest overall stroke incidence, no longer ranks the highest.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 3. Sex-standardized annual incidence per 100 000 of all types of stroke combined for the group aged 75 to 84 years. Studies are arranged in ascending order of incidence rates. The numbers shown are point estimates, and the error bars are 95% confidence intervals.

Rates for Pathological Types
Studies suitable for comparison of pathological types defined as in Table 3Up are shown in Table 4Up. The Umbria and Oxfordshire studies17 19 both used Guy's Hospital Stroke Diagnosis Score35 to increase the pathological diagnosis rate. Neither Auckland33 nor Novosibirsk34 had high enough rates of CT scanning to be included in the comparison of all pathological types, but they were included in the comparison of rates of SAH and of all other types of stroke combined, shown in Fig 4Down. We were able to include the Warsaw study, in which no SAHs were counted, in this part of the comparison.32 We had to use the more restricted age group of 45 to 74 years here because the Warsaw study did not have separate denominator age groups >=80 years, and two other studies (Oxfordshire and Umbria) had denominator numbers only in mid-decade 10-year age bands. The proportion of total strokes in this age group that were SAHs varied between studies from just over 2% to almost 9%. However, the numbers of SAHs were very small, with wide confidence intervals around the incidence rates, so that the variation seen in the figure could be simply due to chance. The differences between studies in the rates of all other stroke types combined followed a pattern similar to that seen in Fig 2Up, with especially high rates in Novosibirsk and low rates in Dijon. All the other studies, including the Warsaw study on this occasion, were very similar.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 4. Age- and sex-standardized annual incidence per 100 000 of SAH versus all other pathological types combined for the group aged 45 to 74 years. Studies are arranged in ascending order of incidence of the combined pathological types other than SAH. The numbers shown are point estimates, and the error bars are 95% confidence intervals. na indicates not applicable.

Eight studies were suitable for examining pathological types of stroke separately. In the data set provided by the Rochester group, strokes in the undetermined pathology category, which constituted a very small proportion, were assumed to be CIs (because of their similar prognosis at follow-up in this data set) and categorized as such. The age- and sex-standardized rates for the group aged 45 to 84 years are shown in Table 5Down. Except for CI, the numbers are small and the confidence intervals are wide. If we allow for this, the percent distribution of pathological types shown in Fig 5Down is similar for all the studies examined.


View this table:
[in this window]
[in a new window]
 
Table 5. Age- and Sex-Standardized Annual Incidence per 100 000 of Pathological Types of Stroke in Group Aged 45-84 Years



View larger version (39K):
[in this window]
[in a new window]
 
Figure 5. Percent distribution of pathological types of stroke for the group aged 45 to 84 years. The numbers shown are percentage estimates. UND indicates undetermined type.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowAppendix 1
down arrowReferences
 
There is little variation to be found in the incidence of all types of stroke combined among the studies considered here. This is perhaps not surprising, given that all the populations studied were predominantly white with a westernized lifestyle. However, the study from France has strikingly low rates. This could simply be artifact, relating to methodological differences, most likely in case finding, but it raises the possibility that the so-called French paradox—low rates of cardiovascular disease in France, attributed by some to wine consumption36 37 —applies to stroke as well as to ischemic heart disease. Further reliable stroke incidence studies from this part of the world are needed to investigate this possibility. The much higher rates in Novosibirsk may also be due to methodological artifact or may indicate a real difference, reflecting a higher level of population risk factors for stroke. However, stroke rates in Novosibirsk do not rank as high in the elderly. The reasons are not clear. Perhaps case finding among older people in this population was less efficient. Another possibility is that there are fewer stroke-prone people in this age group because of earlier deaths from complications of ischemic heart disease in a population with a high prevalence of risk factors for both cardiovascular and cerebrovascular disease.

The approximately 2.5-fold difference between stroke incidence in Dijon and Novosibirsk is considerably less than the approximately 8-fold difference in mortality (from official statistics) between France and Russia.38 While it is possible that the much larger mortality difference could be due to higher case fatality in Russia, another potential explanation is that mortality statistics are simply not reliable enough to reflect accurately international variation in stroke incidence.

In regard to pathological types, no striking differences in distribution are seen, but the studies contributing to the analysis are again drawn from broadly similar types of population. Studies from the Far East show a similar overall incidence rate of stroke to other parts of the world when comparisons have been made. These include the WHO MONICA project,15 with a study from Beijing, China,39 and the review of Malmgren et al in 1987,3 which included an incidence study from Shibata, Japan, from the 1970s.6 However, most of the Far Eastern studies have suggested that the proportion of intracerebral hemorrhages is significantly higher (up to 35%) than in whites.6 39 40 41 42 43 44 Unfortunately, none of these studies fulfill our criteria for a comparable study, and therefore we cannot yet confirm that this excess of hemorrhages is real. This will require studies with comparable methods and high rates of accurate pathological diagnosis.

There is clearly a need to continue and extend this work to include studies in the Middle East, Asia, Africa, and South America. In 1990, official mortality statistics were available for only approximately one third of deaths worldwide,45 and reliable information on stroke incidence is available for only a tiny fraction. Fig 6Down illustrates the paucity of our present knowledge about stroke incidence around the world.



View larger version (43K):
[in this window]
[in a new window]
 
Figure 6. World map showing areas of comparable studies of stroke incidence. Shown are studies included in review of Malmgren et al3 ({bullet}); studies included in WHO MONICA stroke incidence comparison15 ({blacksquare}); and studies included in current comparison ({blacktriangleup}).

Future collaborative comparisons could also include a consideration of case fatality, which was estimated in many comparable incidence studies. This may eventually help us to determine whether international mortality differences are due to differences in incidence, case fatality, or both or are just an artifact. Attempting to determine reasons for any differences cannot be justified unless they are real. Only then can they possibly further our knowledge about the etiology and prevention of the third most common cause of death in the Western world.


*    Selected Abbreviations and Acronyms
 
CI = cerebral infarction
MONICA = Monitoring Trends and Determinants in Cardiovascular Disease
PICH = primary intracerebral hemorrhage
SAH = subarachnoid hemorrhage
TIA = transient ischemic attack
WHO = World Health Organization


*    Acknowledgments
 
The worldwide visits for discussions with international investigators were made possible by the kind hospitality of colleagues and friends in Sweden, Denmark, Poland, Italy, France, Japan, Australia, New Zealand, and the United States, with generous financial support from the Edinburgh Stroke Research Fund, the Guarantors of Brain, the Royal College of Physicians of Edinburgh Myre Sim Bequest, Lilly Industries Limited, Bayer plc, and Boehringer Ingelheim Limited. We thank Jim Slattery for his helpful comments on earlier versions of the manuscript.


*    Footnotes
 
A complete list of the participants in this research study appears at the end of this article.


*    Appendix 1
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*Appendix 1
down arrowReferences
 
Collaborators were as follows: Auckland, New Zealand: R. Bonita, J. Broad; Dijon, France: M. Giroud, M. Lemesle; Frederiksberg, Denmark: H.S. Jorgensen; Oxfordshire, UK: M.S. Dennis, P.A.G. Sandercock, C.P. Warlow; Novosibirsk, Russia: V. Feigin, Y. Nikitin, A. Tarasov, T. Vinogradova; Perth, Australia: C. Anderson, P.W. Burvill, T.M. Chakera, G. Hankey, K. Jamrozik, E. Stewart-Wynne; Rochester, Minn: R. Brown, D. Wiebers, J. Whisnant; Söderhamn, Sweden: A. Terent; Umbria, Italy: M.-G. Celani, S. Ricci; Valle d'Aosta, Italy: G. D'Alessandro; and Warsaw, Poland: A. Czlonkowska, D. Ryglewicz.

Received August 20, 1996; revision received November 4, 1996; accepted November 19, 1996.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
up arrowAppendix 1
*References
 
1. Bonita R, Stewart A, Beaglehole R. International trends in stroke mortality: 1970-1985. Stroke. 1990;21:989-992. [Abstract/Free Full Text]

2. Sudlow CLM, Warlow CP. Comparing stroke incidence worldwide: what makes studies comparable? Stroke. 1996;27:550-558. [Abstract/Free Full Text]

3. Malmgren R, Warlow C, Bamford J, Sandercock P. Geographical and secular trends in stroke incidence. Lancet. 1987;2:1196-1200. [Medline] [Order article via Infotrieve]

4. Terent A. A prospective epidemiological survey of cerebrovascular disease in a Swedish community. Ups J Med Sci. 1979;84:235-246. [Medline] [Order article via Infotrieve]

5. Garraway WM, Whisnant JP, Drury I. The continuing decline in the incidence of stroke. Mayo Clin Proc. 1983;58:520-523. [Medline] [Order article via Infotrieve]

6. Tanaka H, Ueda Y, Date C, Baba T, Yamashita H, Hayashi M, Shoji H, Owada K, Baba K, Shibuya M, Koa T, Detels R. Incidence of stroke in Shibata, Japan: 1976-1978. Stroke. 1981;12:460-466. [Abstract/Free Full Text]

7. Herman B, Schulte BP, van Luijk JH, Leyten AC, Frenken CW. Epidemiology of stroke in Tilberg, the Netherlands: the population-based stroke incidence register, I: introduction and preliminary results. Stroke. 1980;11:162-165. [Abstract/Free Full Text]

8. Herman B, Leyten AC, van Luijk JH, Frenken CW, Op de Coul AA, Schulte BP. Epidemiology of stroke in Tilberg, the Netherlands: the population-based stroke incidence register, II: incidence, initial clinical picture and medical care, and three week case fatality. Stroke. 1982;13:629-634. [Abstract/Free Full Text]

9. Kotila M. Declining incidence and mortality of stroke? Stroke. 1984;15:255-259. [Abstract/Free Full Text]

10. Bonita R, Beaglehole R, North JD. The long-term monitoring of cardiovascular disease: is it feasible? Community Health Stud. 1983;7:111-116. [Medline] [Order article via Infotrieve]

11. Bonita R, Beaglehole R, North JD. Event, incidence and case fatality rates of cerebrovascular disease in Auckland, New Zealand. Am J Epidemiol. 1984;120:236-243. [Abstract/Free Full Text]

12. Ashok PP, Radhakrishnan K, Sridharan R, el-Mangoush MA. Incidence and pattern of cerebrovascular diseases in Benghazi, Libya. J Neurol Neurosurg Psychiatry. 1986;49:519-523. [Abstract/Free Full Text]

13. Terent A. Increasing incidence of stroke amongst Swedish women. Stroke. 1988;19:598-603. [Abstract/Free Full Text]

14. Sandercock PAG, Warlow CP, Price SM. Incidence of stroke in Oxfordshire: first year's experience: Oxfordshire Community Stroke Project. Br Med J. 1983;287:713-717.

15. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas A, Schroll M, for the WHO MONICA Project. Stroke incidence, case fatality, and mortality in the WHO MONICA Project. Stroke. 1995;26:361-367. [Abstract/Free Full Text]

16. Whisnant JP, Melton LJ, Davis PH, O'Fallon WM, Nishimaru K, Schoenberg BS. Comparison of case ascertainment by medical record linkage and cohort follow-up to determine incidence rates for transient ischemic attacks and stroke. J Clin Epidemiol. 1990;43:791-794. [Medline] [Order article via Infotrieve]

17. Ricci S, Celani MG, La Rosa F, Vitali R, Duca E, Ferraguzzi R, Paolotti M, Seppoloni D, Caputo N, Chirulla C, Scaroni R, Signorini E. SEPIVAC: a community-based study of stroke incidence in Umbria, Italy. J Neurol Neurosurg Psychiatry. 1991;54:695-698. [Abstract/Free Full Text]

18. Bamford J, Sandercock P, Dennis M, Warlow C, Jones L, McPherson K, Vessey M, Fowler G, Molyneux A, Hughes T, Burn J, Wade D. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86, I: methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry. 1988;51:1373-1380. [Abstract/Free Full Text]

19. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-1986, II: incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1990;53:16-22. [Abstract/Free Full Text]

20. Waterhouse J, ed. Cancer Incidence in Five Continents. Lyon, France: IARC; 1976.

21. Gardner MJ, Altman DG. Statistics With Confidence. London, England: British Medical Journal Publications; 1989:61-62.

22. Bonita R, Broad JB, Anderson NE, Beaglehole R. Approaches to the problems measuring the incidence of stroke: the Auckland Stroke Study, 1991-1992. Int J Epidemiol. 1995;24:535-542. [Abstract/Free Full Text]

23. Sandercock PAG, Warlow CP, Price SM. Incidence of stroke in Oxfordshire: first year's experience: Oxfordshire Community Stroke Project. Br Med J. 1983;287:713-717.

24. Giroud M, Milan C, Beuriat P, Gras P, Essayagh E, Arveux P, Dumas R. Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks: the stroke registry of Dijon: 1985-1989. Int J Epidemiol. 1991;20:892-899. [Abstract/Free Full Text]

25. Giroud M, Beuriat P, Vion P, D'Athis PH, Dusserre L, Dumas R. Stroke in a French prospective population study. Neuroepidemiology. 1989;8:97-104. [Medline] [Order article via Infotrieve]

26. Giroud M, Gras P, Chadan N, Beuriat P, Milan C, Arveux P, Dumas R. Cerebral haemorrhage in a French prospective population study. J Neurol Neurosurg Psychiatry. 1991;54:595-598. [Abstract/Free Full Text]

27. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence and survival: secular trends in Rochester, Minnesota, through 1989. Stroke. 1996;27:373-380.

28. D'Alessandro G, Di Giovanni M, Roveyaz L, Ianizzi L, Compagnoni MP, Blanc S, Bottacchi E. Incidence and prognosis of stroke in the Valle d'Aosta, Italy: first-year results of a community-based study. Stroke. 1992;23:1712-1715. [Abstract/Free Full Text]

29. Jorgensen HS, Plesner AM, Hubbe P, Larsen K. Marked increase of stroke incidence in men between 1972 and 1990 in Frederiksberg, Denmark. Stroke. 1992;23:1701-1704. [Abstract/Free Full Text]

30. Anderson CS, Jamrozik KD, Burvill PW, Chakera TM, Johnson GA, Stewart-Wynne EG. Ascertaining the true incidence of stroke: experience from the Perth Community Stroke Study, 1989-1990. Med J Aust. 1993;158:80-84. [Medline] [Order article via Infotrieve]

31. Anderson CS, Jamrozik KD, Burvill PW, Chakera TM, Johnson GA, Stewart-Wynne EG. Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke Study, 1989-1990. Med J Aust. 1993;158:85-89. [Medline] [Order article via Infotrieve]

32. Czlonkowska A, Ryglewicz D, Weissbein T, Baranska-Gieruszczak M, Hier DB. A prospective community-based study of stroke in Warsaw, Poland. Stroke. 1994;25:547-551. [Abstract]

33. Bonita R, Broad JB, Beaglehole R. Changes in stroke incidence and case-fatality in Auckland, New Zealand, 1981-91. Lancet. 1993;342:1470-1473. [Medline] [Order article via Infotrieve]

34. Feigin VL, Wiebers DO, Nikitin YP, O'Fallon WM, Whisnant JP. Stroke epidemiology in Novosibirsk, Russia: a population-based study. Mayo Clin Proc. 1995;70:847-852. [Abstract]

35. Sandercock P, Allen C, Corston R, Harrison M, Warlow C. Clinical diagnosis of intracranial haemorrhage using Guy's Hospital score. Br Med J. 1985;291:1675-1677.

36. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet. 1994;344:1719-1723. [Medline] [Order article via Infotrieve]

37. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas A, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Circulation. 1994;1990:583-612.

38. World Health Organisation. World Health Statistics Annual, 1993. Geneva, Switzerland; WHO; 1994.

39. Chen D, Roman GC, Wu GX, Wu ZS, Yao CH, Zhang M, Hirsch RP. Stroke in China (Sino-MONICA-Beijing study) 1984-1986. Neuroepidemiology. 1992;11:15-23. [Medline] [Order article via Infotrieve]

40. Hong Y, Bots ML, Pan X, Hofman A, Grobbee DE, Chen H. Stroke incidence and mortality in rural and urban Shanghai from 1984 through 1991: findings from a community-based registry. Stroke. 1994;25:1165-1169. [Abstract]

41. Kinjo K, Kimura Y, Shinzato Y, Tomori M, Komine Y, Kawazoe N, Takashita S, Fukiyama K. An epidemiological analysis of cardiovascular diseases in Okinawa, Japan. Hypertens Res. 1992;15:111-119.

42. Hu H, Sheng W, Chu F, Lan C, Chiang B. Incidence of stroke in Taiwan. Stroke. 1992;23:1237-1241. [Abstract/Free Full Text]

43. Suzuki K, Kutsuzawa T, Takita K, Ito M, Sakamoto T, Hirayama A, Ito T, Ishida T, Ooishi H, Kawakami K, Hirota K, Ogasawara T, Toshida J, Tamura T, Hattori S, Iwabuchi S, Karouji Y, Waga T, Oosato Y, Yazaki K, Saito T, Oouchi T, Kojima S. Clinico-epidemiological study of stroke in Akita, Japan. Stroke. 1987;18:402-406. [Abstract/Free Full Text]

44. Kay R, Woo J, Kreel L, Wong HY, Tech R, Nicholls MG. Stroke subtypes among Chinese living in Hong Kong: the Shatia Stroke Registry. Neurology. 1992;42:985-987. [Abstract/Free Full Text]

45. Murray CJL, Lopez AD. Global and regional cause-of-death patterns in 1990. Bull World Health Organ.. 1994;72:447-480.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
J. Neurosci.Home page
L. Sela, Y. Sacher, C. Serfaty, Y. Yeshurun, N. Soroker, and N. Sobel
Spared and Impaired Olfactory Abilities after Thalamic Lesions
J. Neurosci., September 30, 2009; 29(39): 12059 - 12069.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
N L Cabral, A R R Goncalves, A L Longo, C H C Moro, G Costa, C H Amaral, L A M Fonseca, and J Eluf-Neto
Incidence of stroke subtypes, prognosis and prevalence of risk factors in Joinville, Brazil: a 2 year community based study
J. Neurol. Neurosurg. Psychiatry, July 1, 2009; 80(7): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. W. Crowley, H. K. Yeoh, G. J. Stukenborg, R. Medel, N. F. Kassell, and A. S. Dumont
Influence of Weekend Hospital Admission on Short-Term Mortality After Intracerebral Hemorrhage
Stroke, July 1, 2009; 40(7): 2387 - 2392.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. Liang, A. H. Lee, C. W. Binns, R. Huang, D. Hu, and Q. Zhou
Tea Consumption and Ischemic Stroke Risk: A Case-Control Study in Southern China
Stroke, July 1, 2009; 40(7): 2480 - 2485.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. L. Bailey, J. McCulloch, C. Sudlow, and J. M. Wardlaw
Potential Animal Models of Lacunar Stroke: A Systematic Review
Stroke, June 1, 2009; 40(6): e451 - e458.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. N. Doubal, T. J. MacGillivray, P. E. Hokke, B. Dhillon, M. S. Dennis, and J. M. Wardlaw
Differences in retinal vessels support a distinct vasculopathy causing lacunar stroke
Neurology, May 19, 2009; 72(20): 1773 - 1778.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Appelros, B. Stegmayr, and A. Terent
Sex Differences in Stroke Epidemiology: A Systematic Review
Stroke, April 1, 2009; 40(4): 1082 - 1090.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F N Doubal, P E Hokke, and J M Wardlaw
Retinal microvascular abnormalities and stroke: a systematic review
J. Neurol. Neurosurg. Psychiatry, February 1, 2009; 80(2): 158 - 165.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
J. A. McManus, A. Craig, C. McAlpine, P. Langhorne, and G. Ellis
Does behaviour modification affect post-stroke risk factor control? Three-year follow-up of a randomized controlled trial
Clinical Rehabilitation, February 1, 2009; 23(2): 99 - 105.
[Abstract] [PDF]


Home page
StrokeHome page
S. Sacco, C. Marini, D. Toni, L. Olivieri, and A. Carolei
Incidence and 10-Year Survival of Intracerebral Hemorrhage in a Population-Based Registry
Stroke, February 1, 2009; 40(2): 394 - 399.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
F. N. Doubal, B. Dhillon, M. S. Dennis, and J. M. Wardlaw
Retinopathy in Ischemic Stroke Subtypes
Stroke, February 1, 2009; 40(2): 389 - 393.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Ali, S. Atula, P. M.W. Bath, J. Grotta, W. Hacke, P. Lyden, J. R. Marler, R. L. Sacco, K. R. Lees, and for the VISTA Investigators
Stroke Outcome in Clinical Trial Patients Deriving From Different Countries
Stroke, January 1, 2009; 40(1): 35 - 40.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Manobianca, S. Zoccolella, A. Petruzzellis, A. Miccoli, and G. Logroscino
Low Incidence of Stroke in Southern Italy: A Population-Based Study
Stroke, November 1, 2008; 39(11): 2923 - 2928.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Covic, A. Schiller, N.-G. Mardare, L. Petrica, M. Petrica, A. Mihaescu, and N. Posta
The impact of acute kidney injury on short-term survival in an Eastern European population with stroke
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2228 - 2234.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Md. S. Islam, C. S. Anderson, G. J. Hankey, K. Hardie, K. Carter, R. Broadhurst, and K. Jamrozik
Trends in Incidence and Outcome of Stroke in Perth, Western Australia During 1989 to 2001: The Perth Community Stroke Study
Stroke, March 1, 2008; 39(3): 776 - 782.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. L. Chaichana, A. P. Levy, R. Miller-Lotan, S. Shakur, and R. J. Tamargo
Haptoglobin 2-2 Genotype Determines Chronic Vasospasm After Experimental Subarachnoid Hemorrhage
Stroke, December 1, 2007; 38(12): 3266 - 3271.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
C. Strom Moller, J. Haggstrom, B. Zethelius, B. Wiberg, J. Sundstrom, and L. Lind
Age and follow-up time affect the prognostic value of the ECG and conventional cardiovascular risk factors for stroke in adult men
J Epidemiol Community Health, August 1, 2007; 61(8): 704 - 712.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Arnold, L. Kappeler, K. Nedeltchev, C. Brekenfeld, U. Fischer, B. Keserue, L. Remonda, G. Schroth, and H. P. Mattle
Recanalization and Outcome After Intra-Arterial Thrombolysis in Middle Cerebral Artery and Internal Carotid Artery Occlusion: Does Sex Matter?
Stroke, April 1, 2007; 38(4): 1281 - 1285.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Bondanelli, M. R. Ambrosio, A. Onofri, A. Bergonzoni, S. Lavezzi, M. C. Zatelli, D. Valle, N. Basaglia, and E. C. degli Uberti
Predictive Value of Circulating Insulin-Like Growth Factor I Levels in Ischemic Stroke Outcome
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3928 - 3934.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. El-Saed, L. H. Kuller, A. B. Newman, O. Lopez, J. Costantino, K. McTigue, M. Cushman, and R. Kronmal
Geographic Variations in Stroke Incidence and Mortality Among Older Populations in Four US Communities
Stroke, August 1, 2006; 37(8): 1975 - 1979.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Kubo, Y. Kiyohara, T. Ninomiya, Y. Tanizaki, K. Yonemoto, Y. Doi, J. Hata, Y. Oishi, K. Shikata, and M. Iida
Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population
Neurology, May 23, 2006; 66(10): 1539 - 1544.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C Foerch, I Curdt, B Yan, F Dvorak, M Hermans, J Berkefeld, A Raabe, T Neumann-Haefelin, H Steinmetz, and M Sitzer
Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke
J. Neurol. Neurosurg. Psychiatry, February 1, 2006; 77(2): 181 - 184.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
M.O. McCarron, G. Davey Smith, and P. McCarron
Secular stroke trends: early life factors and future prospects
QJM, February 1, 2006; 99(2): 117 - 122.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. H. Choi, B. T. Bateman, S. Mangla, R. S. Marshall, S. Prabhakaran, J. Chong, J. P. Mohr, H. Mast, and J. Pile-Spellman
Endovascular Recanalization Therapy in Acute Ischemic Stroke
Stroke, February 1, 2006; 37(2): 419 - 424.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. I. Suarez, R. W. Tarr, and W. R. Selman
Aneurysmal Subarachnoid Hemorrhage
N. Engl. J. Med., January 26, 2006; 354(4): 387 - 396.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M J Ariesen, A Algra, C P Warlow, P M Rothwell, and on behalf of the Cerebrovascular Cohort Studies Co
Predictors of risk of intracerebral haemorrhage in patients with a history of TIA or minor ischaemic stroke
J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 92 - 94.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Steiner, J. Rosand, and M. Diringer
Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy: Current Practices and Unresolved Questions
Stroke, January 1, 2006; 37(1): 256 - 262.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Musolino, P. La Spina, S. Serra, P. Postorino, S. Calabro, R. Savica, G. Salemi, and G. Gallitto
First-Ever Stroke Incidence and 30-Day Case Fatality in the Sicilian Aeolian Archipelago, Italy
Stroke, December 1, 2005; 36(12): 2738 - 2741.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Razmara, D. N. Krause, and S. P. Duckles
Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1843 - H1850.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Stirone, S. P. Duckles, D. N. Krause, and V. Procaccio
Estrogen Increases Mitochondrial Efficiency and Reduces Oxidative Stress in Cerebral Blood Vessels
Mol. Pharmacol., October 1, 2005; 68(4): 959 - 965.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. C. Kim, C. M. Nam, S. H. Jee, and I. Suh
Comparison of Blood Pressure-Associated Risk of Intracerebral Hemorrhage and Subarachnoid Hemorrhage: Korea Medical Insurance Corporation Study
Hypertension, August 1, 2005; 46(2): 393 - 397.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
L. L. Tosi, B. D. Boyan, and A. L. Boskey
Does Sex Matter in Musculoskeletal Health? The Influence of Sex and Gender on Musculoskeletal Health
J. Bone Joint Surg. Am., July 1, 2005; 87(7): 1631 - 1647.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J M Wardlaw
What causes lacunar stroke?
J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 617 - 619.
[Full Text] [PDF]


Home page
NeurologyHome page
M. A. Ritter, D. W. Droste, K. Hegedus, R. Szepesi, D. G. Nabavi, L. Csiba, and E. B. Ringelstein
Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients
Neurology, April 12, 2005; 64(7): 1233 - 1237.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
A. van der Gaag, L. Smith, S. Davis, B. Moss, V. Cornelius, S. Laing, and C. Mowles
Therapy and support services for people with long-term stroke and aphasia and their relatives: a six-month follow-up study
Clinical Rehabilitation, April 1, 2005; 19(4): 372 - 380.
[Abstract] [PDF]


Home page
Br J AnaesthHome page
J. B. Springborg, H.-J. Frederiksen, V. Eskesen, and N. V. Olsen
Trends in monitoring patients with aneurysmal subarachnoid haemorrhage
Br. J. Anaesth., March 1, 2005; 94(3): 259 - 270.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. D. Hurn, S. J. Vannucci, and H. Hagberg
Adult or Perinatal Brain Injury: Does Sex Matter?
Stroke, February 1, 2005; 36(2): 193 - 195.
[Full Text] [PDF]


Home page
StrokeHome page
A. Kitamura, H. Iso, H. Imano, T. Ohira, T. Okada, S. Sato, M. Kiyama, T. Tanigawa, K. Yamagishi, and T. Shimamoto
Carotid Intima-Media Thickness and Plaque Characteristics as a Risk Factor for Stroke in Japanese Elderly Men
Stroke, December 1, 2004; 35(12): 2788 - 2794.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Tsiskaridze, M. Djibuti, G. van Melle, G. Lomidze, S. Apridonidze, I. Gauarashvili, B. Piechowski-Jozwiak, R. Shakarishvili, and J. Bogousslavsky
Stroke Incidence and 30-Day Case-Fatality in a Suburb of Tbilisi: Results of the First Prospective Population-Based Study in Georgia
Stroke, November 1, 2004; 35(11): 2523 - 2528.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. T. Pendlebury, P. M. Rothwell, A. Algra, M.-J. Ariesen, G. Bakac, A. Czlonkowska, A. Dachenhausen, Y. Krespi, J. Korv, K. Krolikowski, et al.
Underfunding of Stroke Research: A Europe-Wide Problem
Stroke, October 1, 2004; 35(10): 2368 - 2371.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Correia, M. R. Silva, I. Matos, R. Magalhaes, J. C. Lopes, J. M. Ferro, and M. C. Silva
Prospective Community-Based Study of Stroke in Northern Portugal: Incidence and Case Fatality in Rural and Urban Populations
Stroke, September 1, 2004; 35(9): 2048 - 2053.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W.-D. Niesen, M. Rosenkranz, W. Schummer, C. Weiller, and U. Sliwka
Cerebral Venous Flow Velocity Predicts Poor Outcome in Subarachnoid Hemorrhage
Stroke, August 1, 2004; 35(8): 1873 - 1878.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
G. J Hankey
Informal care giving for disabled stroke survivors
BMJ, May 8, 2004; 328(7448): 1085 - 1086.
[Full Text] [PDF]


Home page
BMJHome page
C. Ham, N. York, R. Shaw, and S. Sutch
Hospital bed utilisation in the NHS and Kaiser Permanente: Authors' reply
BMJ, March 6, 2004; 328(7439): 584 - 584.
[Full Text]


Home page
StrokeHome page
R. Launois, M. Giroud, A.C. Megnigbeto, K. Le Lay, G. Presente, M.H. Mahagne, I. Durand, and A.F. Gaudin
Estimating the Cost-Effectiveness of Stroke Units in France Compared With Conventional Care
Stroke, March 1, 2004; 35(3): 770 - 775.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
S. L Morris, K. J Dodd, and M. E Morris
Outcomes of progressive resistance strength training following stroke: a systematic review
Clinical Rehabilitation, January 1, 2004; 18(1): 27 - 39.
[Abstract] [PDF]


Home page
StrokeHome page
J. Kelly, B.J. Hunt, R.R. Lewis, and A. Rudd
Anticoagulation or Inferior Vena Cava Filter Placement for Patients With Primary Intracerebral Hemorrhage Developing Venous Thromboembolism?
Stroke, December 1, 2003; 34(12): 2999 - 3005.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. A. Gregson and A. D. Mendelow
International Variations in Surgical Practice for Spontaneous Intracerebral Hemorrhage
Stroke, November 1, 2003; 34(11): 2593 - 2597.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L.-F. Zhang, J. Yang, Z. Hong, G.-G. Yuan, B.-F. Zhou, L.-C. Zhao, Y.-N. Huang, J. Chen, and Y.-F. Wu
Proportion of Different Subtypes of Stroke in China
Stroke, September 1, 2003; 34(9): 2091 - 2096.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
U.G.R. Schulz and P.M. Rothwell
Differences in Vascular Risk Factors Between Etiological Subtypes of Ischemic Stroke: Importance of Population-Based Studies
Stroke, August 1, 2003; 34(8): 2050 - 2059.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. G. Thrift
Editorial Comment--Minor Risk Factors for Intracerebral Hemorrhage: The Jury Is Still Out
Stroke, August 1, 2003; 34(8): 2065 - 2066.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
A. W. E. Weverling-Rijnsburger, I. J. A. M. Jonkers, E. van Exel, J. Gussekloo, and R. G. J. Westendorp
High-Density vs Low-Density Lipoprotein Cholesterol as the Risk Factor for Coronary Artery Disease and Stroke in Old Age
Arch Intern Med, July 14, 2003; 163(13): 1549 - 1554.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M R Law, N J Wald, and A R Rudnicka
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
BMJ, June 25, 2003; 326(7404): 1423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Ospina, S. P. Duckles, and D. N. Krause
17{beta}-Estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation
Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H241 - H250.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Y. Liu, A. K. Death, and D. J. Handelsman
Androgens and Cardiovascular Disease
Endocr. Rev., June 1, 2003; 24(3): 313 - 340.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Terent
Trends in Stroke Incidence and 10-Year Survival in Soderhamn, Sweden, 1975-2001
Stroke, June 1, 2003; 34(6): 1353 - 1358.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Pessah-Rasmussen, G. Engstrom, I. Jerntorp, and L. Janzon
Increasing Stroke Incidence and Decreasing Case Fatality, 1989-1998: A Study From the Stroke Register in Malmo, Sweden
Stroke, April 1, 2003; 34(4): 913 - 918.
[Abstract] [Full Text] [PDF]


Home page
ImagingHome page
J M Wardlaw
Recent developments in imaging of stroke
Imaging, October 1, 2002; 14(5): 409 - 419.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. G. Thrift and G. A. Donnan
RE: "DOES TEA AFFECT CARDIOVASCULAR DISEASE? A META-ANALYSIS"
Am. J. Epidemiol., September 1, 2002; 156(5): 490 - 490.
[Full Text] [PDF]


Home page
StrokeHome page
T. S. Field, M. D. Hill, and M. D. Connor
Weather, Chinook, and Stroke Occurrence * Editorial Comment
Stroke, July 1, 2002; 33(7): 1751 - 1758.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. F. Meschia, D. A. Miller, and T. G. Brott
Thrombolytic Treatment of Acute Ischemic Stroke
Mayo Clin. Proc., June 1, 2002; 77(6): 542 - 551.
[Abstract] [PDF]


Home page
StrokeHome page
G. J. Hankey, K. Jamrozik, R. J. Broadhurst, S. Forbes, and C. S. Anderson
Long-Term Disability After First-Ever Stroke and Related Prognostic Factors in the Perth Community Stroke Study, 1989-1990
Stroke, April 1, 2002; 33(4): 1034 - 1040.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C D A Wolfe, A G Rudd, R Howard, C Coshall, J Stewart, E Lawrence, C Hajat, and T Hillen
Incidence and case fatality rates of stroke subtypes in a multiethnic population: the South London Stroke Register
J. Neurol. Neurosurg. Psychiatry, February 1, 2002; 72(2): 211 - 216.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. G. Thrift, G. A. Donnan, and J. J. McNeil
Reduced Risk of Intracerebral Hemorrhage With Dynamic Recreational Exercise but Not With Heavy Work Activity
Stroke, February 1, 2002; 33(2): 559 - 564.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. A. Ospina, D. N. Krause, and S. P. Duckles
17{beta}-Estradiol Increases Rat Cerebrovascular Prostacyclin Synthesis by Elevating Cyclooxygenase-1 and Prostacyclin Synthase
Stroke, February 1, 2002; 33(2): 600 - 605.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. W. Albers, L. B. Goldstein, D. Hall, L. M. Lesko, and for the Aptiganel Acute Stroke Investigators
Aptiganel Hydrochloride in Acute Ischemic Stroke: A Randomized Controlled Trial
JAMA, December 5, 2001; 286(21): 2673 - 2682.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Milhaud, J. Bogousslavsky, G. van Melle, and P. Liot
Ischemic stroke and active migraine
Neurology, November 27, 2001; 57(10): 1805 - 1811.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. Al-Shahi and C. Warlow
A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults
Brain, October 1, 2001; 124(10): 1900 - 1926.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Mihalka, V. Smolanka, B. Bulecza, S. Mulesa, and D. Bereczki
A Population Study of Stroke in West Ukraine: Incidence, Stroke Services, and 30-Day Case Fatality
Stroke, October 1, 2001; 32(10): 2227 - 2231.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. G. Thrift, H. M. Dewey, R. A.L. Macdonell, J. J. McNeil, and G. A. Donnan
Incidence of the Major Stroke Subtypes: Initial Findings From the North East Melbourne Stroke Incidence Study (NEMESIS)
Stroke, August 1, 2001; 32(8): 1732 - 1738.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. van Gijn and G. J. E. Rinkel
Subarachnoid haemorrhage: diagnosis, causes and management
Brain, February 1, 2001; 124(2): 249 - 278.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
D. Leys
Atherothrombosis - the neurologist's point of view
Vascular Medicine, February 1, 2001; 6(1_suppl): 17 - 19.
[Abstract] [PDF]


Home page
StrokeHome page
P. Saloheimo, S. Juvela, and M. Hillbom
Use of Aspirin, Epistaxis, and Untreated Hypertension as Risk Factors for Primary Intracerebral Hemorrhage in Middle-Aged and Elderly People
Stroke, February 1, 2001; 32(2): 399 - 404.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K N Vemmos, M L Bots, P K Tsibouris, V P Zis, C E Takis, D E Grobbee, and S Stamatelopoulos
Prognosis of stroke in the south of Greece: 1 year mortality, functional outcome and its determinants: the Arcadia Stroke Registry
J. Neurol. Neurosurg. Psychiatry, November 1, 2000; 69(5): 595 - 600.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Y. Tanizaki, Y. Kiyohara, I. Kato, H. Iwamoto, K. Nakayama, N. Shinohara, H. Arima, K. Tanaka, S. Ibayashi, and M. Fujishima
Incidence and Risk Factors for Subtypes of Cerebral Infarction in a General Population : The Hisayama Study
Stroke, November 1, 2000; 31(11): 2616 - 2622.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. D.A. Wolfe, M. Giroud, P. Kolominsky-Rabas, R. Dundas, M. Lemesle, P. Heuschmann, and A. Rudd
Variations in Stroke Incidence and Survival in 3 Areas of Europe
Stroke, September 1, 2000; 31(9): 2074 - 2079.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. G. Thrift, H. M. Dewey, R. A. L. Macdonell, J. J. McNeil, and G. A. Donnan
Stroke Incidence on the East Coast of Australia : The North East Melbourne Stroke Incidence Study (NEMESIS)
Stroke, September 1, 2000; 31(9): 2087 - 2092.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. Moncayo, G. Devuyst, G. Van Melle, and J. Bogousslavsky
Coexisting Causes of Ischemic Stroke
Arch Neurol, August 1, 2000; 57(8): 1139 - 1144.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Ingall, K. Asplund, M. Mahonen, and R. Bonita
A Multinational Comparison of Subarachnoid Hemorrhage Epidemiology in the WHO MONICA Stroke Study
Stroke, May 1, 2000; 31(5): 1054 - 1061.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. R. Williams, J. G. Jiang, D. B. Matchar, and G. P. Samsa
Incidence and Occurrence of Total (First-Ever and Recurrent) Stroke
Stroke, December 1, 1999; 30(12): 2523 - 2528.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
G. J. Hankey
Stroke: How Large a Public Health Problem, and How Can the Neurologist Help?
Arch Neurol, June 1, 1999; 56(6): 748 - 754.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M.-G. Bousser
Stroke in Women : The 1997 Paul Dudley White International Lecture
Circulation, February 2, 1999; 99(4): 463 - 467.
[Full Text] [PDF]


Home page
StrokeHome page
G. P. Samsa, J. Bian, J. Lipscomb, and D. B. Matchar
Epidemiology of Recurrent Cerebral Infarction : A Medicare Claims–Based Comparison of First and Recurrent Strokes on 2-Year Survival and Cost
Stroke, February 1, 1999; 30(2): 338 - 349.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. N. Vemmos, M. L. Bots, P. K. Tsibouris, V. P. Zis, D. E. Grobbee, G. S. Stranjalis, and S. Stamatelopoulos
Stroke Incidence and Case Fatality in Southern Greece : The Arcadia Stroke Registry
Stroke, February 1, 1999; 30(2): 363 - 370.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Lemesle, C. Milan, J. Faivre, T. Moreau, M. Giroud, and R. Dumas
Incidence Trends of Ischemic Stroke and Transient Ischemic Attacks in a Well-Defined French Population From 1985 Through 1994
Stroke, February 1, 1999; 30(2): 371 - 377.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sudlow, C.L.M.
Right arrow Articles by Warlow, C.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sudlow, C.L.M.
Right arrow Articles by Warlow, C.P.